DiscoverAt the Intersection of Science and LawLife sciences companies and the risks posed by the mifepristone litigation
Life sciences companies and the risks posed by the mifepristone litigation

Life sciences companies and the risks posed by the mifepristone litigation

Update: 2023-05-19
Share

Description

In this episode, a cross-disciplinary team of FDA regulatory lawyers and life sciences litigators discuss the implications of the mifepristone litigation for life sciences companies as it pertains to citizen petitions, FDA approvals, and strategies manufacturers might consider going forward.

See omnystudio.com/listener for privacy information.

Comments 
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
In Channel
Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

Revolutionizing Clinical Trials: A discussion on diversity and patient-centric approaches

2024-11-1529:38

Life sciences companies and the risks posed by the mifepristone litigation

Life sciences companies and the risks posed by the mifepristone litigation

2023-05-1933:18

Trade secrets protection in the life sciences sector

Trade secrets protection in the life sciences sector

2023-04-1221:23

Cross-border considerations for privacy in clinical trials

Cross-border considerations for privacy in clinical trials

2023-02-0618:19

Global Life Sciences Supply Chain Insights

Global Life Sciences Supply Chain Insights

2022-11-0327:36

AI risk assessments: Future-proofing your innovation when rules can change mid-game

AI risk assessments: Future-proofing your innovation when rules can change mid-game

2022-09-0624:43

The rise of global telehealth

The rise of global telehealth

2022-06-0125:35

Advising the advisor: Tips for navigating the life sciences and regulatory environment

Advising the advisor: Tips for navigating the life sciences and regulatory environment

2022-04-1831:00

The moral imperative: Balancing innovation, regulation and prescription drug availability

The moral imperative: Balancing innovation, regulation and prescription drug availability

2022-03-2130:31

Incentivizing diverse representation in clinical trials

Incentivizing diverse representation in clinical trials

2022-03-0222:40

The crossroad of science and law

The crossroad of science and law

2021-12-1626:17

Social media’s impact on the life sciences industry

Social media’s impact on the life sciences industry

2021-11-0834:50

Understanding AI and its use in drug discovery

Understanding AI and its use in drug discovery

2021-10-0531:49

mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando

mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando

2021-09-0326:25

Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Life sciences companies and the risks posed by the mifepristone litigation

Life sciences companies and the risks posed by the mifepristone litigation

DLA Piper